These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9793973)

  • 21. Antenatal diagnosis of fetal digestive (sub)obstruction. Ultrasonic semeiology and follow-up.
    Avni EF; Van Gansbeke D; Matos C; Houben JJ; Delaet MH; Rodesch F
    J Belge Radiol; 1986; 69(4):241-6. PubMed ID: 3531160
    [No Abstract]   [Full Text] [Related]  

  • 22. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
    Gross SJ; Phillips OP; Shulman LP; Bright NL; Dungan JS; Simpson JL; Elias S
    Prenat Diagn; 1994 Jul; 14(7):609-13. PubMed ID: 7526367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristic findings for diagnosis of baby complicated with both the VACTERL association and duodenal atresia.
    Fujishiro E; Suzuki Y; Sato T; Kondo S; Miyachi M; Suzumori K
    Fetal Diagn Ther; 2004; 19(2):134-7. PubMed ID: 14764957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    MacDonald ML; Wagner RM; Slotnick RN
    Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal gastrointestinal abnormalities.
    Hertzberg BS; Bowie JD
    Radiol Clin North Am; 1990 Jan; 28(1):101-14. PubMed ID: 2136953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal disorders in Down syndrome.
    Bermudez BEBV; de Oliveira CM; de Lima Cat MN; Magdalena NIR; Celli A
    Am J Med Genet A; 2019 Aug; 179(8):1426-1431. PubMed ID: 31183986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
    Hsu JJ; Hseih TT; Liou JD; Soong YK
    J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
    Stiller RJ; de Regt RH; Suntag S; Baumgarten A; Hobbins JC; Mahoney MJ
    Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The relationship between weights of fetuses with autosomal trisomies and low maternal serum alpha-fetoprotein].
    Hsu JJ; Hsieh CC; Chiu TH; Soong YK
    Changgeng Yi Xue Za Zhi; 1992 Mar; 15(1):33-8. PubMed ID: 1374679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
    Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI
    Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does gut atresia cause polyhydramnios?
    Kimble RM; Harding JE; Kolbe A
    Pediatr Surg Int; 1998 Mar; 13(2-3):115-7. PubMed ID: 9563021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal diagnosis of gastrointestinal tract obstruction.
    Duenhoelter JH; Santos-Ramos R; Rosenfeld CR; Coln CD
    Obstet Gynecol; 1976 May; 47(5):618-20. PubMed ID: 772509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E; Brizzi L; Periti E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational age at maternal serum alpha-fetoprotein screening and the detection of Down syndrome.
    Waller K; Lustig L; Hook E
    Am J Hum Genet; 1990 Sep; 47(3):581-3. PubMed ID: 1697446
    [No Abstract]   [Full Text] [Related]  

  • 39. Maternal serum alpha-fetoprotein and anal atresia.
    Verp MS
    Prenat Diagn; 1999 Jul; 19(7):689-90. PubMed ID: 10419625
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined esophageal and duodenal atresia: sonographic findings.
    Hayden CK; Schwartz MZ; Davis M; Swischuk LE
    AJR Am J Roentgenol; 1983 Feb; 140(2):225-6. PubMed ID: 6600333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.